Shiseido Future Solution LX Total Protective E

Product NDC
58411-328
11-digit product format
584110328
Labeler code
58411
Product ID
58411-328_2668be02-92ec-4cff-b6de-55d103544607
Type
HUMAN OTC DRUG
Nonproprietary name
AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE
Dosage form
CREAM
Route
TOPICAL
Labeler
SHISEIDO AMERICAS CORPORATION
Application
part352
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2017-08-01
Marketing end
0000-00-00
Substance
AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE
Active strength
1017 mg/50mL; mg/50mL; mg/50mL; mg/50mL
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct58411-328DDiscontinued by firm2026-10-15
excluded packagepackage58411-32858411-328-50DDiscontinued by firm2026-10-15
excluded packagepackage58411-32858411-328-51DDiscontinued by firm2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 6 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage58411-328-50d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage58411-328-51d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage58411-328-50f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage58411-328-51f5e01cc5f278…a2eaf40c39c3…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
58411-328SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE E (AVOBENZONE, OCTINOXATE, OCTOCRYLENE, AND OXYBENZONE) CREAM [SHISEIDO AMERICAS CORPORATION]4Legacy NDC20241228_b233ddca-83f8-426f-8d52-eac93ab239ec.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
58411-328-50584110328501 JAR in 1 CARTON (58411-328-50) > 50 mL in 1 JAR1 jar2017-08-010000-00-00NoNoCurrent
58411-328-51584110328511 JAR in 1 CARTON (58411-328-51) > 30 mL in 1 JAR1 jar2021-05-010000-00-00NoNoCurrent